Muscle gene electrotransfer is increased by the antioxidant tempol in mice

Gene Therapy

Volumn 19, Issue 3, 2012, Pages 312-320

  Markelc, B ^a   Tevz, G ^a   Cemazar, M ^a   Kranjc, S ^a   Lavrencak, J ^a   Zegura, B ^b   Teissie, J ^c,d   Sersa, G ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

electropermeabilization; gene electrotransfer; muscle; reactive oxygen species; tempol

Indexed keywords

ASCORBIC ACID; PLASMID DNA; REACTIVE OXYGEN METABOLITE; TEMPOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DNA DAMAGE; ELECTROPORATION; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; IN VIVO STUDY; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; ANTIOXIDANTS; CELL LINE; CELL SURVIVAL; CYCLIC N-OXIDES; ELECTROPORATION; FEMALE; GENE TRANSFER TECHNIQUES; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYOBLASTS; PLASMIDS; REACTIVE OXYGEN SPECIES; SPIN LABELS;

MUS;

EID: 84858005870     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.97     Document Type: Article

References (55)

1. Teissie J, Golzio M, Rols MP. Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim Biophys Acta 2005; 1724: 270-280.
2. Miklavcic D, Towhidi L. Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells. Radiol Oncol 2010; 44: 34-41.
3. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M et al. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 2010; 9: 10.
4. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 2008; 34: 232-240.
5. Moller MG, Salwa S, Soden DM, O'Sullivan GC. Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma. Expert Rev Anticancer Ther 2009; 9: 1611-1630.
6. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M et al. Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3-13. (Pubitemid 44755131)
7. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1: 841-845.
8. Titomirov AV, Sukharev S, Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1991; 1088: 131-134.
9. Cemazar M, Golzio M, Sersa G, Rols MP, Teissie J. Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des 2006; 12: 3817-3825. (Pubitemid 44560715)
10. Mir LM. Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future. Mol Biotechnol 2009; 43: 167-176.
11. Vidic S, Markelc B, Sersa G, Coer A, Kamensek U, Tevz G et al. MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo. Cancer Gene Ther 2010; 17: 409-419.
12. Marshall Jr WG, Boone BA, Burgos JD, Gografe SI, Baldwin MK, Danielson ML et al. Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression. Gene Therapy 2010; 17: 419-423.
13. Aung W, Hasegawa S, Koshikawa-Yano M, Obata T, Ikehira H, Furukawa T et al. Visualization of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging. Gene Therapy 2009; 16: 830-839.
14. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870. (Pubitemid 28405859)
15. Gehl J, Mir LM. Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 1999; 261: 377-380. (Pubitemid 29392484)
16. Gehl J, Sorensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T et al. In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999; 1428: 233-240. (Pubitemid 29352271)
17. Lucas ML, Heller R. Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol Ther 2001; 3: 47-53. (Pubitemid 32509804)
18. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96: 4262-4267. (Pubitemid 29190324)
19. Mir LM, Bureau MF, Rangara R, Schwartz B, Scherman D. Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III 1998; 321: 893-899. (Pubitemid 29532909)
20. Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26: 5896-5903.
21. Hojman P. Basic principles and clinical advancements of muscle electrotransfer. Curr Gene Ther 2010; 10: 128-138.
22. Burattini S, Ferri P, Battistelli M, Curci R, Luchetti F, Falcieri E. C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. Eur J Histochem 2004; 48: 223-233.
23. Cemazar M, Jarm T, Sersa G. Cancer electrogene therapy with interleukin-12. Curr Gene Ther 2010; 10: 300-311.
24. Heller LC, Heller R. Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 2010; 10: 312-317.
25. Pavlin D, Cemazar M, Cör A, Sersa G, Pogacnik A, Tozon N. Electrogene therapy with interleukin-12 in canine mast cell tumors. Radiol Oncol 2011; 45: 30-39.
26. Bodles-Brakhop AM, Heller R, Draghia-Akli R. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol Ther 2009; 17: 585-592.
27. Andre F, Gehl J, Sersa G, Preat V, Hojman P, Eriksen J et al. Efficiency of high and low voltage pulse combinations for gene electrotransfer in muscle, liver, tumor and skin. Hum Gene Ther 2008; 19: 1261-1271.
28. Cemazar M, Golzio M, Sersa G, Hojman P, Kranjc S, Mesojednik S et al. Control by pulse parameters of DNA electrotransfer into solid tumors in mice. Gene Therapy 2009; 16: 635-644.
29. Tevz G, Pavlin D, Kamensek U, Kranjc S, Mesojednik S, Coer A et al. Gene electro-transfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression. Technol Cancer Res Treat 2008; 7: 91-101. (Pubitemid 351555616)
30. Roos AK, Eriksson F, Walters DC, Pisa P, King AD. Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients. Mol Ther 2009; 17: 1637-1642.
31. Vry JD, Martinez-Martinez P, Losen M, Bode GH, Temel Y, Steckler T et al. Low current-driven micro-electroporation allows efficient in vivo delivery of nonviral DNA into the adult mouse brain. Mol Ther 2010; 18: 1183-1191.
32. Hojman P, Gissel H, Andre FM, Cournil-Henrionnet C, Eriksen J, Gehl J et al. Physiological effects of high- and low-voltage pulse combinations for gene electro-transfer in muscle. Hum Gene Ther 2008; 19: 1249-1260.
33. Zupanic A, Corovic S, Miklavcic D, Pavlin M. Numerical optimization of gene electro-transfer into muscle tissue. Biomed Eng Online 2010; 9: 66.
34. Gabriel B, Teissie J. Control by electrical parameters of short- and long-term cell death resulting from electropermeabilization of Chinese hamster ovary cells. Biochim Biophys Acta 1995; 1266: 171-178.
35. Heller LC, Cruz YL, Ferraro B, Yang H, Heller R. Plasmid injection and application of electric pulses alter endogenous mRNA and protein expression in B16.F10 mouse melanomas. Cancer Gene Ther 2010; 17: 864-871.
36. Hojman P, Zibert JR, Gissel H, Eriksen J, Gehl J. Gene expression profiles in skeletal muscle after gene electrotransfer. BMC Mol Biol 2007; 8: 56.
37. Rubenstrunk A, Mahfoudi A, Scherman D. Delivery of electric pulses for DNA electro-transfer to mouse muscle does not induce the expression of stress related genes. Cell Biol Toxicol 2004; 20: 25-31. (Pubitemid 38478128)
38. Bonnafous P, Vernhes M, Teissie J, Gabriel B. The generation of reactive-oxygen species associated with long-lasting pulse-induced electropermeabilisation of mammalian cells is based on a non-destructive alteration of the plasma membrane. Biochim Biophys Acta 1999; 1461: 123-134. (Pubitemid 30077468)
39. Gabriel B, Teissie J. Generation of reactive-oxygen species induced by electropermeabilization of Chinese hamster ovary cells and their consequence on cell viability. Eur J Biochem 1994; 223: 25-33. (Pubitemid 24221642)
40. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003; 17: 1195-1214. (Pubitemid 36775767)
41. Keller TJ, Oppenheimer NJ. Enhanced bleomycin-mediated damage of DNA opposite charged nicks. A model for bleomycin-directed double strand scission of DNA. J Biol Chem 1987; 262: 15144-15150. (Pubitemid 17160179)
42. Gabriel B, Teissie J. Spatial compartmentation and time resolution of photooxidation of a cell membrane probe in electropermeabilized Chinese hamster ovary cells. Eur J Biochem 1995; 228: 710-718.
43. Sabri N, Pelissier B, Teissie J. Electropermeabilization of intact maize cells induces an oxidative stress. Eur J Biochem 1996; 238: 737-743. (Pubitemid 26235115)
44. Shil P, Sanghvi SH, Vidyasagar PB, Mishra KP. Enhancement of radiation cytotoxicity in murine cancer cells by electroporation: in vitro and in vivo studies. J Environ Pathol Toxicol Oncol 2005; 24: 291-298.
45. Goldberg A, Rubinsky B. The effect of electroporation type pulsed electric fields on DNA in aqueous solution. Technol Cancer Res Treat 2010; 9: 423-430.
46. Faurie C, Rebersek M, Golzio M, Kanduser M, Escoffre JM, Pavlin M et al. Electro-mediated gene transfer and expression are controlled by the life-time of DNA/membrane complex formation. J Gene Med 2010; 12: 117-125.
47. Sabri N, Pelissier B, Teissie J. Ascorbate increases electrotransformation efficiency of intact maize cells. Anal Biochem 1998; 264: 284-286. (Pubitemid 28536907)
48. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev 2008; 60: 418-469.
49. Wilcox CS. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther 2010; 126: 119-145.
50. Mesojednik S, Pavlin D, Sersa G, Coer A, Kranjc S, Grosel A et al. The effect of the histological properties of tumors on transfection efficiency of electrically assisted gene delivery to solid tumors in mice. Gene Therapy 2007; 14: 1261-1269. (Pubitemid 47299951)
51. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000; 35: 206-221. (Pubitemid 30196665)
52. Collins AR, Duthie SJ, Dobson VL. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 1993; 14: 1733-1735. (Pubitemid 23290881)
53. Zegura B, Lah TT, Filipic M. The role of reactive oxygen species in microcystin-LR-induced DNA damage. Toxicology 2004; 200: 59-68. (Pubitemid 38680687)
54. Collins AR, Dusinska M, Gedik CM, Stetina R. Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 1996; 104 (Suppl 3): 465-469. (Pubitemid 26197677)
55. Miklos M, Gajski G, Garaj-Vrhovac V. Usage of the standard and modified comet assay in assessment of DNA damage in human lymphocytes after exposure to ionizing radiation. Radiol Oncol 2009; 43: 97-107.